Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

42.44
Delayed Data
As of 4:00pm ET
 +0.28 / +0.66%
Today’s Change
33.60
Today|||52-Week Range
50.40
+11.25%
Year-to-Date
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
6:43pm / GuruFocus News - Paid Partner Content
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
Feb 22 / GuruFocus News - Paid Partner Content
3 Top Healthcare Stocks to Buy Now
4:31pm / MotleyFool.com - Paid Partner Content
Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat
Feb 22 / MotleyFool.com - Paid Partner Content
These 3 Big Pharma Stocks Are Ridiculously Cheap
Feb 26 / MotleyFool.com - Paid Partner Content
Drug Addiction Treatment Stocks to Watch
Feb 22 / GuruFocus News - Paid Partner Content
Mylan (MYL) to Post Q4 Earnings: Will the Stock Disappoint?
Feb 24 / Zacks.com - Paid Partner Content
Where Are the Best Buying Opportunities in Stocks Right Now?
Feb 21 / Zacks.com - Paid Partner Content
Fore Research & Management, LP Buys CA, Vodafone Group PLC, LiLAC Group, Sells Centra...
Feb 23 / GuruFocus News - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close42.16
Today’s open42.14
Day’s range41.77 - 42.50
Volume4,060,275
Average volume (3 months)5,696,538
Market cap$22.6B
Dividend yield--
Data as of 4:00pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+10.25%
Earnings growth (next 5 years)+7.25%
Revenue growth (last year)+21.91%
P/E ratio18.3
Price/Sales2.84
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+2.83+3.29%
INCYIncyte Corp+2.81+2.14%
ZTSZoetis Inc-0.05-0.09%
BAXBaxter International...-0.05-0.10%
Data as of 4:00pm ET, 02/27/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$1.42
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts


Search for Jobs